Stock PTI PROTEOSTASIS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Proteostasis Therapeutics, Inc.

Equities

PTI

US74373B1098

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Proteostasis Therapeutics, Inc.(NasdaqGM:PTI) dropped from NASDAQ Composite Index
CI
Proteostasis Therapeutics, Inc. : Stockholders Approve Business Combination with Yumanity Therapeutics, Inc.; Board Sets Reverse Stock Split Ratio
PR
Yumanity Therapeutics Inc. completed the acquisition of Proteostasis Therapeutics, Inc. in a reverse merger transaction.
CI
PROTEOSTASIS THERAPEUTICS, INC. : Other Events (form 8-K)
AQ
PROTEOSTASIS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
PROTEOSTASIS THERAPEUTICS, INC. : Other Events (form 8-K)
AQ
PROTEOSTASIS THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Proteostasis: 3Q Earnings Snapshot
AQ
Proteostasis: 3Q Earnings Snapshot
AQ
Proteostasis Therapeutics, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
CI
Proteostasis Therapeutics : Reports Third Quarter 2020 Financial Results
PR
PROTEOSTASIS THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
PROTEOSTASIS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
WeissLaw LLP : Reminds BYFC, OTEL and PTI Shareholders About Its Ongoing Investigations
PR
PROTEOSTASIS THERAPEUTICS, INC. : Change in Directors or Principal Officers, Other Events (form 8-K)
AQ
PROTEOSTASIS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Proteostasis Therapeutics, Inc. - PTI
BU
WeissLaw LLP Investigates Proteostasis Therapeutics, Inc.
PR
PROTEOSTASIS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Costs Associated with Exit or Disposal Activities, Material Modification to Rights of Security Holders, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Proteostasis Therapeutics, Inc. Announces Resignation of Sheila Wilson as Chief Operating Officer
CI
Proteostasis Therapeutics : Biotech Startup Yumanity Sets Reverse Merger With Proteostasis
DJ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PTI Stock
  4. News Proteostasis Therapeutics, Inc.